Verastem Oncology Announces Stock Option Inducement Grants for New Employees Under Nasdaq Rule

Reuters
07-08
<a href="https://laohu8.com/S/VSTM">Verastem</a> Oncology Announces Stock Option Inducement Grants for New Employees Under Nasdaq Rule

Verastem Oncology, a biopharmaceutical company, announced the grant of stock options to purchase 45,000 shares of its common stock to four new employees. These stock options were granted under the Nasdaq inducement grant exception as part of the employees' compensation package upon joining the company. The stock options have an exercise price of $4.29 per share, based on the closing price on July 1, 2025. The vesting schedule for these options begins with twenty-five percent vesting on the one-year anniversary of the employee's hire date, with the remainder vesting quarterly over the next three years, contingent upon continued employment with Verastem Oncology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verastem Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250708443632) on July 08, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10